Enzo Biochem, Inc (NYSE:ENZ)’s traded shares stood at 1.1 million during the last session, with the company’s beta value hitting 1.09. At the close of trading, the stock’s price was $0.33, to imply an increase of 2.80% or $0.01 in intraday trading. The ENZ share’s 52-week high remains $1.16, putting it -251.52% down since that peak but still an impressive 24.24% since price per share fell to its 52-week low of $0.25. The company has a valuation of $17.51M, with an average of 0.52 million shares in intraday trading volume over the past 10 days and average of 181.51K shares over the past 3 months.
Enzo Biochem, Inc (NYSE:ENZ) trade information
After registering a 2.80% upside in the last session, Enzo Biochem, Inc (ENZ) has traded red over the past five days. The 5-day price performance for the stock is 0.48%, and -25.59% over 30 days. With these gigs, the year-to-date price performance is -53.23%. Short interest in Enzo Biochem, Inc (NYSE:ENZ) saw shorts transact 0.31 million shares and set a 2.75 days time to cover.
ENZ Dividends
Enzo Biochem, Inc has its next earnings report out in May. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Enzo Biochem, Inc (NYSE:ENZ)’s Major holders
Enzo Biochem, Inc insiders hold 21.68% of total outstanding shares, with institutional holders owning 34.80% of the shares at 44.43% float percentage. In total, 34.80% institutions holds shares in the company, led by HARBERT FUND ADVISORS, INC.. As of 2024-06-30, the company held over 5.18 million shares (or 9.9072% of shares), all amounting to roughly $5.64 million.
The next major institution holding the largest number of shares is RENAISSANCE TECHNOLOGIES LLC with 2.5 million shares, or about 4.7844% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $2.72 million.
We also have VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the Enzo Biochem, Inc (ENZ) shares. Going by data provided on Dec 31, 2024 , VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund holds roughly 1.19 shares. This is just over 2.27% of the total shares, with a market valuation of $0.4 million. Data from the same date shows that the other fund manager holds a little less at 618.88, or 1.18% of the shares, all valued at about 0.21 million.
